Trial intelligence / Profile preview

Paclitaxel-HDFL in Gastric Cancer

NCT00154726Phase 2Completed

Sponsor
National Taiwan University Hospital
Start
Apr 1997
Modality
Small Molecules
01

Overview

Phase 2, open-label, single-arm trial of paclitaxel in gastric cancer (GC), sponsored by National Taiwan University Hospital. Primary endpoint: Response Rate. Started Apr 1997; status: completed.

02

Drugs

paclitaxel
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00154726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00154726.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call